Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4989)
All Articles published online
|
Jul 21, 2010 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Montalto M, Gallo A, Ianiro G, Santoro L, D’Onofrio F, Ricci R, Cammarota G, Covino M, Vastola M, Gasbarrini A, Gasbarrini G. Can chronic gastritis cause an increase in fecal calprotectin concentrations? World J Gastroenterol 2010; 16(27): 3406-3410 [PMID: 20632443 DOI: 10.3748/wjg.v16.i27.3406] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i27/3406.htm |
| Number | Citing Articles |
| 1 |
Fatma Demirbaş, Gönül Çaltepe, Hasan Abbasguliyev, Ayhan Gazi Kalaycı. Fecal calprotectin levels used as a noninvasive method for screening for chronic gastritis in pediatric patients. A descriptive study. Sao Paulo Medical Journal 2021; 139(6): 564 doi: 10.1590/1516-3180.2020.0765.r1.0904221
|
| 2 |
Kristiina Aalto, Pekka Lahdenne, Kaija-Leena Kolho. Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use. Pediatric Rheumatology 2017; 15(1) doi: 10.1186/s12969-016-0132-2
|
| 3 |
Cliodna A. M. McNulty, Philippe Lehours, Francis Mégraud. Diagnosis of Helicobacter pylori Infection. Helicobacter 2011; 16(s1): 10 doi: 10.1111/j.1523-5378.2011.00875.x
|
| 4 |
Emanuel Burri, Christoph Beglinger. The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Review of Gastroenterology & Hepatology 2014; 8(2): 197 doi: 10.1586/17474124.2014.869476
|
| 5 |
Pedram Ataee, Vahidreza Afrasiabi, Bahram Nikkhoo, Mehri Najafi Sani, Ramesh Rahehagh, Ebrahim Ghaderi, Maryam Monajemzadeh, Asadollah Fathollahpour, Banafsheh Sedaghat, Froozan Kariminejhad, Jaleh Parizad, Kambiz Eftekhari. Relationship Between Fecal Calprotectin and Upper Endoscopy Findings in Children With Upper Gastrointestinal Symptoms. Iranian Journal of Pediatrics 2017; 27(3) doi: 10.5812/ijp.8658
|
| 6 |
Josef Sýkora, Michal Huml, Konrad Siala, Renáta Pomahačová, Petr Jehlička, Jiří Liška, Jana Kuntscherová, Jan Schwarz. Paediatric Rome III Criteria–Related Abdominal Pain Is Associated With Helicobacter pylori and Not With Calprotectin. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(4): 417 doi: 10.1097/MPG.0000000000001172
|
| 7 |
Juntao Kan, Junrui Cheng, Leiming Xu, Molly Hood, Dingfu Zhong, Meijiao Cheng, Yumin Liu, Liang Chen, Jun Du. The combination of wheat peptides and fucoidan protects against chronic superficial gastritis and alters gut microbiota: a double-blinded, placebo-controlled study. European Journal of Nutrition 2020; 59(4): 1655 doi: 10.1007/s00394-019-02020-6
|
| 8 |
Yao-Jong Yang, Peng-Chieh Chen, Fu-Ping Lai, Pei-Jane Tsai, Bor-Shyang Sheu. Probiotics-Containing Yogurt Ingestion and H. pylori Eradication Can Restore Fecal Faecalibacterium prausnitzii Dysbiosis in H. pylori-Infected Children. Biomedicines 2020; 8(6): 146 doi: 10.3390/biomedicines8060146
|
| 9 |
Taina Sipponen, Johanna Haapamäki, Erkki Savilahti, Henrik Alfthan, Esa Hämäläinen, Henna Rautiainen, Jari Koskenpato, Hannu Nuutinen, Martti Färkkilä. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy. Scandinavian Journal of Gastroenterology 2012; 47(7): 778 doi: 10.3109/00365521.2012.677953
|
| 10 |
Thomas C. C. Boerlage, Floris Westerink, Dennis C. W. Poland, Inge L. Huibregtse, Yair I. Z. Acherman, Victor E. A. Gerdes. Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients. Obesity Surgery 2016; 26(12): 2974 doi: 10.1007/s11695-016-2222-0
|
| 11 |
Ruth M. Ayling, Klaartje Kok. . Advances in Clinical Chemistry 2018; 87: 161 doi: 10.1016/bs.acc.2018.07.005
|
| 12 |
David Lundgren, Vincy Eklöf, Richard Palmqvist, Johan Hultdin, Pontus Karling. Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy. Scandinavian Journal of Gastroenterology 2019; 54(2): 152 doi: 10.1080/00365521.2019.1566493
|
| 13 |
Ferdinando D’Amico, Stéphane Nancey, Silvio Danese, Laurent Peyrin-Biroulet. A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities. Journal of Crohn's and Colitis 2021; 15(1): 152 doi: 10.1093/ecco-jcc/jjaa093
|
| 14 |
Eun Young Paek, Dae Yong Yi, Ben Kang, Byung-Ho Choe. Fecal calprotectin as a marker of gastrointestinal involvement in pediatric Henoch–Schönlein purpura patients: a retrospective analysis. BMC Pediatrics 2020; 20(1) doi: 10.1186/s12887-020-02263-x
|
| 15 |
Emanuel Burri, Michael Manz, Patricia Schroeder, Florian Froehlich, Livio Rossi, Christoph Beglinger, Frank Serge Lehmann. Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-57
|
| 16 |
Fryderyk Lorenz, Stefan Marklund, Mårten Werner, Richard Palmqvist, Björn Engelbrekt Wahlin, Anders Wahlin. Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation. Scientific Reports 2015; 5(1) doi: 10.1038/srep07920
|